TY - STD TI - NCCN Clinical Practice Guidelines in Oncology. Bladder Cancer Version 2. 2018. Available from www.nccn.org/professionals/physician_gls/pdf/bladder.pdf. Accessed 15 May 2018. UR - http://www.nccn.org/professionals/physician_gls/pdf/bladder.pdf ID - ref1 ER - TY - JOUR AU - von der Maase, H. AU - Hansen, S. W. AU - Roberts, J. T. AU - Dogliotti, L. AU - Oliver, T. AU - Moore, M. J. PY - 2000 DA - 2000// TI - Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study JO - J Clin Oncol VL - 18 UR - https://doi.org/10.1200/JCO.2000.18.17.3068 DO - 10.1200/JCO.2000.18.17.3068 ID - von der Maase2000 ER - TY - JOUR AU - Motzer, R. J. AU - Niedzwiecki, D. AU - Isaacs, M. AU - Menendez-Botet, C. AU - Tong, W. P. AU - Flombaum, C. PY - 1990 DA - 1990// TI - Carboplatin-based chemotherapy with pharmacokinetic analysis for patients with hemodialysis-dependent renal insufficiency JO - Cancer Chemother Pharmacol VL - 27 UR - https://doi.org/10.1007/BF00685719 DO - 10.1007/BF00685719 ID - Motzer1990 ER - TY - JOUR AU - Wada, T. AU - Fukuda, T. AU - Kawanishi, M. AU - Tasaka, R. AU - Imai, K. AU - Yamauchi, M. PY - 2016 DA - 2016// TI - Pharmacokinetic analyses of carboplatin in a patient with cancer of the fallopian tubes undergoing hemodialysis: a case report JO - Biomed Rep VL - 5 UR - https://doi.org/10.3892/br.2016.714 DO - 10.3892/br.2016.714 ID - Wada2016 ER - TY - JOUR AU - Oguri, T. AU - Shimokata, T. AU - Ito, I. AU - Yasuda, Y. AU - Sassa, N. AU - Nishiyama, M. PY - 2015 DA - 2015// TI - Extension of the Calvert formula to patients with severe renal insufficiency JO - Cancer Chemother Pharmacol VL - 76 UR - https://doi.org/10.1007/s00280-015-2769-9 DO - 10.1007/s00280-015-2769-9 ID - Oguri2015 ER - TY - JOUR AU - Hiraike, M. AU - Hiraki, Y. AU - Misumi, N. AU - Hanada, K. AU - Tsuji, Y. AU - Kamimura, H. PY - 2012 DA - 2012// TI - Pharmacokinetics of carboplatin in a hemodialysis patient with small-cell lung cancer JO - Cancer Chemother Pharmacol VL - 69 UR - https://doi.org/10.1007/s00280-011-1802-x DO - 10.1007/s00280-011-1802-x ID - Hiraike2012 ER - TY - JOUR AU - Oguri, T. AU - Shimokata, T. AU - Inada, M. AU - Ito, I. AU - Ando, Y. AU - Sasaki, Y. PY - 2010 DA - 2010// TI - Pharmacokinetic analysis of carboplatin in patients with cancer who are undergoing hemodialysis JO - Cancer Chemother Pharmacol VL - 66 UR - https://doi.org/10.1007/s00280-010-1366-1 DO - 10.1007/s00280-010-1366-1 ID - Oguri2010 ER - TY - JOUR AU - Kodama, J. AU - Sasaki, A. AU - Masahiro, S. AU - Seki, N. AU - Kusumoto, T. AU - Nakamura, K. PY - 2010 DA - 2010// TI - Pharmacokinetics of combination chemotherapy with paclitaxel and carboplatin in a patient with advanced epithelial ovarian cancer undergoing hemodialysis JO - Oncol Lett VL - 1 UR - https://doi.org/10.3892/ol_00000090 DO - 10.3892/ol_00000090 ID - Kodama2010 ER - TY - JOUR AU - Suzuki, S. AU - Koide, M. AU - Sakamoto, S. AU - Matsuo, T. PY - 1997 DA - 1997// TI - Pharmacokinetics of carboplatin and etoposide in a haemodialysis patient with Merkel-cell carcinoma JO - Nephrol Dial Transplant VL - 12 UR - https://doi.org/10.1093/ndt/12.1.137 DO - 10.1093/ndt/12.1.137 ID - Suzuki1997 ER - TY - JOUR AU - Calvert, A. H. AU - Newell, D. R. AU - Gumbrell, L. A. AU - O'Reilly, S. AU - Burnell, M. AU - Boxall, F. E. PY - 1989 DA - 1989// TI - Carboplatin dosage: prospective evaluation of a simple formula based on renal function JO - J Clin Oncol VL - 7 UR - https://doi.org/10.1200/JCO.1989.7.11.1748 DO - 10.1200/JCO.1989.7.11.1748 ID - Calvert1989 ER - TY - JOUR AU - Nogué-Aliguer, M. AU - Carles, J. AU - Arrivi, A. AU - Juan, O. AU - Alonso, L. AU - Font, A. PY - 2003 DA - 2003// TI - Gemcitabine and carboplatin in advanced transitional cell carcinoma of the urinary tract: an alternative therapy JO - Cancer VL - 97 UR - https://doi.org/10.1002/cncr.10990 DO - 10.1002/cncr.10990 ID - Nogué-Aliguer2003 ER - TY - CHAP AU - Olyaei Aj, L. E. V. AU - Tuchman, S. A. AU - Sparks, M. A. ED - Jhaveri, K. D. ED - Salahudeen, A. K. PY - 2015 DA - 2015// TI - Rational dosing of chemotherapy in patients with kidney failure BT - Onconephrology: Cancer, chemotherapy and kidney PB - Springer CY - New York ID - Olyaei Aj2015 ER - TY - JOUR AU - Fukuhara, S. AU - Bito, S. AU - Green, J. AU - Hsiao, A. AU - Kurokawa, K. PY - 1998 DA - 1998// TI - Translation, adaptation, and validation of the SF-36 health survey for use in Japan JO - J Clin Epidemiol VL - 51 UR - https://doi.org/10.1016/S0895-4356(98)00095-X DO - 10.1016/S0895-4356(98)00095-X ID - Fukuhara1998 ER - TY - JOUR AU - Fortner, B. V. AU - Schwartzberg, L. AU - Tauer, K. AU - Houts, A. C. AU - Hackett, J. AU - Stolshek, B. S. PY - 2005 DA - 2005// TI - Impact of chemotherapy-induced neutropenia on quality of life: a prospective pilot investigation JO - Support Care Cancer VL - 13 UR - https://doi.org/10.1007/s00520-004-0757-4 DO - 10.1007/s00520-004-0757-4 ID - Fortner2005 ER - TY - JOUR AU - Lyman, G. H. AU - Kuderer, N. M. AU - Crawford, J. AU - Wollf, D. A. AU - Culakova, E. AU - Poniewierski, M. S. PY - 2011 DA - 2011// TI - Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapy JO - Cancer VL - 117 UR - https://doi.org/10.1002/cncr.25691 DO - 10.1002/cncr.25691 ID - Lyman2011 ER -